Atrium Innovations Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Westmount Canada (1999)
Status: Acquired by Nestle (2017)

Organization Overview

First Clinical Trial
2000
NCT02088411
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Atrium Innovations

Active Ingredients

Drugs in Phase 4 Trials (1)

Key: Atrium Innovations (0) Acquired (1)

wobenzyme (6 trials)

Drugs in Phase 3 Trials (2)

Key: Atrium Innovations (0) Acquired (2)

anacaulase (NexoBrid) (1 trial)

trypsin (1 trial)

Drugs in Phase 2 Trials (1)

Key: Atrium Innovations (0) Acquired (1)

diclofenac (voltaren) (1 trial)

Drugs in Other Trials (5)

agave (1 trial)

cranberry (1 trial)

curcumin (1 trial)

d-ribose (1 trial)

resveratrol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Overview

  • Highest Phase: Phase 0
  • # of Trials: 10
  • # of Trial APIs: 9